Acetic acid bacteria, the fermentative microorganisms of traditional foods, have unique and highly pure membrane lipid components such as sphingolipids (dihydroceramide). Sphingolipids are important components of brain tissue and many indirect studies demonstrated that ingestion of ceramide or its sphingolipid-derivatives might have beneficial effects on cognitive function. In a double-blind experiment, we tested whether continuous ingestion of the acetic acid bacterium, Acetobacter malorum NCI 1683 (S24) derived from fermented milk, could improve cognitive function in healthy middle-aged and elderly persons. Cognitive function was evaluated using the CogHealth battery of tasks that can detect slight variations. A 12-week supplement of Acetobacter malorum significantly shortened the response times of the working memory, the primary outcome of this study, compared to the placebo supplement (P<0.05). The working memory and delayed recall tasks in the low-dosage group (111 mg/day), and the choice reaction and delayed recall tasks in the high-dosage group (400 mg/day) were also improved at 8 or 12 weeks when compared to those observed before treatment (P<0.05). These results suggest that the continuous ingestion of Acetobacter malorum has a beneficial effect on cognitive function. No clinical problems were observed in the physical and medical examinations of any of the groups. These results and the historic experiences with eating fermented foods indicate that an intake of acetic acid bacteria is safe and beneficial for the life of elderly persons through the maintenance of cognitive function from the early stages of aging.
Introduction
Acetic acid bacteria, the traditional vinegar-brewing bacteria, are responsible for the fermentation processes resulting in vinegar, nata de coco 1) and fermented milk such as kefir 2) and Caspian Sea yogurt 3) , among others. They have characteristic membrane lipid components limited to some gram-negative bacteria, containing phospholipids (e.g., phosphatidylcholine), hopanoids (terpenoid compounds), sphingolipids, amino lipids and coenzyme Q 4-7) . There are only a few reports characterizing the sphingolipids present in bacteria associated with fermented foods. All of the sphingolipids in acetic acid bacteria have sphinganine as the sphingoid base and 2-hydroxypalmitoyl-sphinganine (dihydroceramide) as the main compound 5, 7) . On the other hand, higher organisms, such as animals and plants, contain a large variety of sphingolipids, and dihydroceramide-containing sphingolipids are only minor component 8) . Therefore, acetic acid bacteria are unique in accumulating dihydroceramide in such a high purity.
In animals, dihydroceramide is converted to ceramide, which is then metabolized into various sphingolipids. Many studies have demonstrated that sphingolipids are important lipid components of brain tissue. For example, gangliosides, composed of sialic acid and oligosaccharides conjugated to ceramide, have been reported to improve the symptoms of Alzheimer's disease patients by subcutaneous injection 9) . In vitro studies have been demonstrated that gangliosides participate in the formation of synapses, and are related to the action of nerve growth factor 10, 11) . Furthermore, ceramide and sphingomyelin, a derivative of ceramide, have been reported to have the function of nerve growth factors and affect the development and survival of nerve cells [12] [13] [14] [15] . These indirect evidences suggest that ingestion of ceramide, or its derivatives, might have a beneficial effect on cognitive function.
It is widely accepted that cognitive function deteriorates with advancing age in experimental animals and humans. In humans, functions such as working memory and space orientation deteriorate following the maturation period 16) . It is thought that such deterioration is caused by disorders in synaptic communication 17) .
powder was enclosed in a capsule with cornstarch and sucrose esters of fatty acids. The composition of the supplements in the three different capsules is shown in Table 2 . The content of dihydroceramide was analyzed in such a way that the alkali-stable lipid was extracted from the bacteria according to the previously reported method 7) and the UV absorption at 230 nm of the benzoylated derivative of dihydroceramide in the alkali-stable lipid was detected with HPLC 27) .
Experimental design and procedures
The experiment was set up as a double-blind test that assumed a placebo contrast and comparison between parallel groups of three different supplements. A flow diagram of the experimental design and procedure is shown in Figure 1 . The subjects ingested two capsules a day for 12 weeks. After 4, 8, and 12 weeks of supplementation, the subjects' response times on the CogHealth battery of tasks were analyzed.
Methods of examination
Cognitive function analyses. CogHealth is a laboratory procedure to analyze higher brain functions based on a task-switching test using cards displayed on a computer screen 22, 23, 28) . Culture, language and course of study are reported to have no influences on the test results 22, [29] [30] [31] . The Japanese version of CogHealth was provided by Health Solution, Inc., Tokyo. The following five tasks were conducted for a total of about 30 min. The simple reaction task required the subject to respond as quickly as possible when a playing card was flipped over; and thus measured psychomotor function (speed of processing). The choice reaction task required the subject to respond as quickly as possible when a playing card In attempts to improve such declines in cognitive function, nutritional supplements, such as polyunsaturated fatty acids including docosahexaenoic acid 18, 19) , ginkgo biloba 20) and phosphatidylserine 21) , have been tested. However, the effects of ingested ceramide or its derivatives on cognitive function have not been reported.
Therefore, we focused on the possibility that acetic acid bacteria, containing high concentrations of dihydroceramide, a precursor of the various sphingolipids in the brain, might improve cognitive function in aging. There are historic experiences with ingesting acetic acid bacteria and they are likely to be safe as a food substance. In this study, we tested whether the continuous ingestion of the acetic acid bacterium, Acetobacter malorum derived from traditional fermented food, could improve cognitive function in healthy middle-aged and elderly persons. Cognitive function was evaluated using the CogHealth battery of tasks, which can detect slight variations in cognitive function 22, 23) . We regarded the response time of the working memory task as the primary outcome, which is impaired in individuals with mild cognitive impairment (MCI) compared to healthy controls and correlates with the ages of individuals with MCI 22) .
Methods

Subjects
Healthy male and female subjects (50-69 years old), who lived in Tokyo and Gunma, Japan, were recruited and screened for the study. Persons whose Hasegawa dementia scale-revised (HDS-R) 24) scores were 20 or less points, who habitually ate foods containing acetic acid bacteria, and who used health supplements, medicines, or game instrumentations and books designed to improve cognitive function were excluded from this study. Eligibility was further confirmed based on a physical examination, hematology and urine tests, and on medical history. Persons with health problems such as food allergy, gastrointestinal disease, diabetes, liver disease, renal disease, heart disease, alcoholism or other serious diseases were excluded.
A total of 66 participants (40 women, 26 men; 58.8 ± 0.7 years old) were selected and randomly assigned to three groups (placebo group, acetic acid bacteria low-dosage group, and high-dosage group). The background data of the three groups are shown in Table 1 . There were no significant differences in the mean response times of CogHealth, age, or sex among the three groups.
The experimental protocol was approved by the Ethics Committee of Anti-Aging Science, Inc. (Minato-ku, Tokyo) and conformed to the ethical principles set forth in the Declaration of Helsinki. Voluntary written informed consent was obtained from all participants. The experiment was conducted under the management of medical doctors at Shirasawa Hospital (Director Minoru Shirasawa, Midori-cho, Tatebayashi-shi, Gunma) and Kowa Clinic (Kowa Medical Corporation, Director Tsuyoshi Yamato, Komagome, Toshima-ku, Tokyo).
Acetic acid bacteria supplement
Acetic acid bacteria were isolated from fermented milk by the method of Entani and Masai 25, 26) . The strain was classified by the sequence of its 16S rRNA and by DNA-DNA hybridization as Acetobacter malorum NCI 1683 (S24). The bacteria were homogenized at high pressure and powdered by spray drying. This of the CogHealth tasks were compared among the three groups with the Kruskal Wallis test. Multiple comparisons were performed using the Steel test. HDS-R scores at post-12 weeks were compared with those at pre-supplementation using paired t-tests (two-sided). Table 3 shows the mean response times for the five tasks of the CogHealth test battery in each group at pre-supplementation and at 4, 8, and 12 weeks during supplementation. The mean response times for all five tasks were shorter at each succeeding time point throughout the experiments in all three groups. This may be accounted for by the effects of learning due to repetition of the tasks. In the low-dosage group, the mean response times in the working memory task tended to be shorter than those in the placebo group at each supplementation time point and a significant difference was identified at 12 weeks after supplementation compared to the placebo group. However, no significant differences were found between those of the high-dosage group and the placebo group at any time in any of the tasks.
Results
CogHealth test
In the acetic acid bacteria low-dosage group, the response times in the working memory and delayed recall tasks tended to be shorter at 8 weeks and were significantly shorter at 12 weeks than at pre-supplementation. In the high-dosage group, the response times at 12 weeks for the choice reaction task and at 8 weeks for the delayed recall task were significantly shorter than at pre-supplementation. The high-dosage of acetic acid bacteria also tended to improve the results of the working memory and delayed recall tasks at 12 weeks compared to pre-supplementation. In the placebo group, there were no significant differences or tendencies between the pre-and post-supplementation times in any of the tasks.
was flipped over and to answer whether it was red or not by pressing YES or NO. In the working memory task, the subject was required to decide whether the newly flipped card exactly matched the previous card. The delayed recall task required the subject to decide whether or not the same card had been seen before in the same task and measured visual learning and memory. In the divided attention task, the subject had to respond as quickly as possible when any one of the five cards moving up and down touched a white line above or below the cards. In all cases the participants were instructed to perform the tasks quickly and precisely. The reaction times of each task were evaluated. Physical and medical examinations. Physical examinations consisted of height, body weight, BMI, blood pressure, and pulse rate measurements. Blood samples were analyzed for aspartate transaminase (AST/GOT), alanine transaminase (ALT/GPT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), γ -glutamyl transpeptidase (γ-GTP), total bilirubin, total protein, albumin, A/G ratio, acylglycerol, total cholesterol, HDL-C, LDL-C, urea nitrogen, creatinine, uric acid, Na + , K + , Cl -, blood glucose, HbA1c, red blood cell count, hemoglobinometry, hematocrit, mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), platelet count, and white blood-cell count. Urine samples were analyzed for pH, specific gravity, protein, glucose, occult blood, and urobilinogen. In addition, a medical doctor interviewed participants concerning their subjective symptoms and objective responses. Diary reports. All participants were asked to keep diaries. Here they recorded checkmarks when they consumed the supplements, as well as subjective comments concerning any symptoms, the intake of medicines and other health supplements, body temperature in case of fever, and whether they had loose bowels, diarrhoea, or constipation.
Statistical analysis
One-way repeated measures ANOVA was used to compare the response times of the CogHealth tasks from the pre-and post-4, 8, and 12 weeks supplementation periods and multiple comparisons were performed using a Bonferroni correction. The response times 
Safety evaluation
The results of the HDS-R test and the physical data for each group before and after supplementation are shown in Table 4 . HDS-R scores at the pre-and post-supplementation periods in each group were not significantly different from one another, and the individual variations were within the normal range.
Several variations of other values were shown after supplementation. However, the variations of the systolic and diastolic blood pressures were small and that of the hematology examinations were within the normal range. Clinically morbid manifestations and obvious contributions by the supplements were not identified for all the variations in the individual subjects.
As to adverse events experienced by the subjects during the course of the experiment, except for one case of habitual pollinosis in the placebo group and one case of urticaria in the high-dosage group, subjects recovered from all events within one to ten days. No obvious correlation between the events and the supplements was identified. malorum consists of approximately 1% dry weight of dihydroceramide, approximately 0.8 mg and 2.9 mg of dihydroceramide were consumed per day in the low-dosage and high-dosage supplements, respectively. In addition to sphingolipid, Acetobacter malorum also contain about 5% dry weight of phosphatidylcholine, which is reported to be a nutritional supplement for improving cognitive function 39) , but the amount of phosphatidylcholine ingested in the current study was less than the reported effective dose (1200 mg/day). Gangliosides are reported to act on in vitro neurons at concentrations in the nM range 40, 41) , which is markedly lower than other functional lipids. The dihydroceramide from Acetobacter malorum is thought to be utilized by the human body, and that some of its metabolites, such as gangliosides, may actively affect cognitive function in middle-aged and elderly persons.
In this study, we also confirmed the safety of consuming 111 mg/day and 400 mg/day Acetobacter malorum for 12 weeks. The results of the HDS-R confirmed that there were no serious impairments to cognitive function ( Table 4 ). There were no abnormal variations, clinically morbid manifestations, and specific adverse events in any of the groups after the supplementation in the safety evaluation. These results indicate that an intake of Acetobacter malorum is both safe and beneficial.
In conclusion, the results of this study suggest that the continuous ingestion of acetic acid bacteria derived from traditional fermented food is effective at improving cognitive function in healthy middle-aged and elderly persons, and is safe at the concentrations consumed. Foods containing acetic acid bacteria are expected to contribute to better aging through the maintenance of cognitive function in middle-aged and elderly persons.
It is necessary, however, to obtain further evidence of the effect of acetic acid bacteria on cognitive improvement in subjects with more serious cognitive impairment. It is also important to elucidate the pharmacokinetics of acetic acid bacteria and their mode of action to confirm the relationship of sphingolipids as active ingredients.
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Discussion
In this double-blind experiment, we examined whether continuous ingestion of the acetic acid bacterium, Acetobacter malorum NCI 1683 (S24) derived from traditional fermented food, could improve cognitive function in healthy middle-aged and elderly persons. Acetic acid bacteria are included in nata de coco 1) , fermented milk such as kefir 2) and Caspian Sea yogurt 3) and tea mushrooms (kombucha) 32) , among others 1) . We analysed the content of dihydroceramide in nata de coco; the total dry weight in a 100 g can of nata de coco (Dole Japan, Ltd.) includes 0.8 mg of dihydroceramide. In the low-dosage group, 111.1 mg of Acetobacter malorum corresponding to 0.8 mg of dihydroceramide was supplemented per day. In addition, we had confirmed the safety of consuming 1200 mg/day of Acetobacter malorum for 14 days in a pilot study and 400 mg/day was supplemented in the high-dosage group of this study.
The CogHealth battery of tasks used in this study is reported to be able to detect slight variations in cognitive function 22, 23, 33) . The tasks assess short-term memory (instantaneous memory, working memory) and attention (sustained attention, selective attention, divided attention), which reflect the function of the frontal lobes 22, 23, 28) . We found that the response times of several tasks in the CogHealth battery related to short-term memory (working memory and delayed recall), were significantly improved after the supplementation of Acetobacter malorum ( Table 3) . The response times for the working memory task, which were the primary outcome of this study, was significantly shortened in the low-dosage group compared to the placebo group. This finding demonstrates that the ingestion of Acetobacter malorum has a beneficial effect on cognitive function in healthy middle-aged and elderly persons. In this study, low-dosage group and high-dosage group showed different effects on the response times of several tasks. To provide stronger evidence for the benefit of Acetobacter malorum on cognitive function, it is desirable to ascertain the correlation between the dosage and the effect on each task.
The levels of gangliosides, which are representative derivatives of ceramide in the brain, decrease with age from the juvenile and reach a level of about one-third at 85 years of age 34) . Clinically, gangliosides have been reported to improve the symptoms of stroke patients by intraveneous injection and those of patients with Alzheimer's disease by subcutaneous injection 9) . Gangliosides are known by in vitro studies to accelerate the release of acetylcholine from synapses and to enhance the activity of neurotrophic factors in events such as neuronal dendritic elongation 11, 17) . Ceramide is reported to affect dendrite and axon elongation in in-vitro hippocampal neurons and cerebellar Purkinje cells and the survival of these neurons in rats 13, 14, 35, 36) , to inhibit cytotoxicity by reactive oxygen or amyloid β-peptide 37) , and to participate in the actions of nerve growth factor 12, 15) . These clinical and in vitro studies support the concept that ingested ceramide and its derivatives might have beneficial effects on the decline in cognitive function associated with aging.
Acetic acid bacteria contain dihydroceramide. Dihydroceramide is synthesized from serine and palmitoyl-CoA and has sphinganine as its sphingoid base, which does not contain a double bond in the molecule. On the other hand, in animal tissues, the main sphingoid base is sphingosine, which is an unsaturated molecule. When radiolabeled sphinganine or sphingosine was administered orally to rats, the amounts of sphinganine detected in the intestinal tract lymph were remarkably higher than those of sphingosine 38) , suggesting that the ingested sphinganine-based lipids are more available for absorption and utilization in animal tissues compared with other sphingoid base structures. As Acetobacter 
